FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068449080> ?p ?o ?g. }

• W2068449080 endingPage "1075" @default.
• W2068449080 startingPage "1067" @default.
• W2068449080 abstract "Despite the progress that has been made in the treatment of asthma, the prevalence and burden of this disease has continued to increase. Exercise is a powerful trigger of asthma symptoms and reversible airflow obstruction and may result in the avoidance of physical activity by patients with asthma, resulting in detrimental consequences to their health. Approximately 90% of patients with asthma are hyperresponsive to exercise and experience exercise-induced bronchoconstriction (EIB). While pharmacologic treatment of asthma is usually highly effective, medications often have significant side-effects or exhibit tachyphylaxis. Alternative therapies for treatment (complementary medicine) that reduce the dose requirements of pharmacologic interventions would be beneficial, and could potentially reduce the public health burden of this disease. There is accumulating evidence that dietary modification has potential to influence the severity of asthma and reduce the prevalence and incidence of this condition. A possible contributing factor to the increased incidence of asthma in Western societies may be the consumption of a proinflammatory diet. In the typical Western diet, 20- to 25-fold more ω- 6 polyunsaturated fatty acids (PUFA) than ω-3 PUFA are consumed, which causes the release of proinflammatory arachidonic acid metabolites (leukotrienes and prostanoids). This review analyzes the existing literature on ω-3 PUFA supplementation as a potential modifier of airway hyperresponsiveness in asthma and includes studies concerning the efficacy of ω-3 PUFA supplementation in EIB. While clinical data evaluating the effect of ω-3 PUFA supplementation in asthma has been equivocal, it has recently been shown that pharmaceuticalgrade fish oil (ω-3 PUFA) supplementation reduces airway hyperresponsiveness after exercise, medication use, and proinflammatory mediator generation in nonatopic elite athletes with EIB. These findings are provocative and suggest that dietary ω-3 PUFA supplementation may be a viable treatment modality and/or adjunct therapy in airway hyperresponsiveness. Further studies are needed to confirm these results and understand their mechanism of action." @default.
• W2068449080 created "2016-06-24" @default.
• W2068449080 creator A5065040596 @default.
• W2068449080 creator A5070569112 @default.
• W2068449080 creator A5082103116 @default.
• W2068449080 date "2004-12-01" @default.
• W2068449080 modified "2023-10-18" @default.
• W2068449080 title "Omega-3 Fatty Acids and Airway Hyperresponsiveness in Asthma" @default.
• W2068449080 cites W153234669 @default.
• W2068449080 cites W1623999704 @default.
• W2068449080 cites W189008363 @default.
• W2068449080 cites W1964021868 @default.
• W2068449080 cites W1974668849 @default.
• W2068449080 cites W1975183300 @default.
• W2068449080 cites W1979345635 @default.
• W2068449080 cites W1981878662 @default.
• W2068449080 cites W1984160742 @default.
• W2068449080 cites W1992498330 @default.
• W2068449080 cites W1995017236 @default.
• W2068449080 cites W1996124907 @default.
• W2068449080 cites W1999011146 @default.
• W2068449080 cites W2006417325 @default.
• W2068449080 cites W2014636672 @default.
• W2068449080 cites W2015302965 @default.
• W2068449080 cites W2017340159 @default.
• W2068449080 cites W2023690878 @default.
• W2068449080 cites W2027749415 @default.
• W2068449080 cites W2031835197 @default.
• W2068449080 cites W2040294075 @default.
• W2068449080 cites W2043990114 @default.
• W2068449080 cites W2044136961 @default.
• W2068449080 cites W2044489240 @default.
• W2068449080 cites W2052104030 @default.
• W2068449080 cites W2060682869 @default.
• W2068449080 cites W2065784707 @default.
• W2068449080 cites W2069676636 @default.
• W2068449080 cites W2073980730 @default.
• W2068449080 cites W2074130482 @default.
• W2068449080 cites W2076734255 @default.
• W2068449080 cites W2076870602 @default.
• W2068449080 cites W2076906033 @default.
• W2068449080 cites W2083666530 @default.
• W2068449080 cites W2087009721 @default.
• W2068449080 cites W2089641881 @default.
• W2068449080 cites W2090974883 @default.
• W2068449080 cites W2093586701 @default.
• W2068449080 cites W2093713190 @default.
• W2068449080 cites W2102545533 @default.
• W2068449080 cites W2102997995 @default.
• W2068449080 cites W2103602930 @default.
• W2068449080 cites W2117370193 @default.
• W2068449080 cites W2124661467 @default.
• W2068449080 cites W2128818259 @default.
• W2068449080 cites W2132751563 @default.
• W2068449080 cites W2133437309 @default.
• W2068449080 cites W2139701012 @default.
• W2068449080 cites W2141492787 @default.
• W2068449080 cites W2141972883 @default.
• W2068449080 cites W2142949162 @default.
• W2068449080 cites W2144525186 @default.
• W2068449080 cites W2150630865 @default.
• W2068449080 cites W2155318008 @default.
• W2068449080 cites W2156660340 @default.
• W2068449080 cites W2157487693 @default.
• W2068449080 cites W2157835393 @default.
• W2068449080 cites W2159448938 @default.
• W2068449080 cites W2166229152 @default.
• W2068449080 cites W2169044812 @default.
• W2068449080 cites W2321334948 @default.
• W2068449080 cites W2327515496 @default.
• W2068449080 cites W2336431486 @default.
• W2068449080 cites W2604596332 @default.
• W2068449080 doi "https://doi.org/10.1089/acm.2004.10.1067" @default.
• W2068449080 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15674003" @default.
• W2068449080 hasPublicationYear "2004" @default.
• W2068449080 type Work @default.
• W2068449080 sameAs 2068449080 @default.
• W2068449080 citedByCount "23" @default.
• W2068449080 countsByYear W20684490802012 @default.
• W2068449080 countsByYear W20684490802013 @default.
• W2068449080 countsByYear W20684490802014 @default.
• W2068449080 countsByYear W20684490802019 @default.
• W2068449080 countsByYear W20684490802020 @default.
• W2068449080 countsByYear W20684490802021 @default.
• W2068449080 crossrefType "journal-article" @default.
• W2068449080 hasAuthorship W2068449080A5065040596 @default.
• W2068449080 hasAuthorship W2068449080A5070569112 @default.
• W2068449080 hasAuthorship W2068449080A5082103116 @default.
• W2068449080 hasConcept C126322002 @default.
• W2068449080 hasConcept C164027704 @default.
• W2068449080 hasConcept C178790620 @default.
• W2068449080 hasConcept C185592680 @default.
• W2068449080 hasConcept C19038510 @default.
• W2068449080 hasConcept C203014093 @default.
• W2068449080 hasConcept C2776042228 @default.
• W2068449080 hasConcept C2776178081 @default.
• W2068449080 hasConcept C2776238763 @default.
• W2068449080 hasConcept C2776914184 @default.

• next